2025-12-30 - Analysis Report
Okay, here's a comprehensive analysis of Rocket Lab USA Inc (RKLB) based on the provided data.

**0. Report Overview**

This report summarizes key financial data and market indicators for Rocket Lab USA Inc. (RKLB) to provide an overview of its current investment potential. The analysis includes return comparisons, technical indicators, news events, analyst opinions, earnings data, and financial metrics.

**1. Return Rate Comparison and Analysis**

*   **Ticker:** RKLB
*   **Company:** Rocket Lab USA Inc. (Overview: A space launch and services company)
*   **RKLB Cumulative Return:** 429.47%
*   **VOO (S&P 500) Cumulative Return:** 52.63%
*   **Divergence:** Max: 384.5, Min: -44.6, Current: 378.2, Relative Divergence: 98.5

**Analysis:**

RKLB has significantly outperformed the S&P 500 (VOO) with a cumulative return of 429.47% compared to VOO's 52.63%. The current divergence between RKLB and VOO is high (378.2), with a relative divergence of 98.5, indicating that RKLB's recent performance is near the top of its historical outperformance range compared to the S&P 500. This implies a period of significant outperformance, but it also suggests that such a high level of divergence might not be sustainable in the long term and could be subject to correction.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta  | Cap(B) |
|------------|----------|----------|---------|-------|--------|
| 2020-2022  | -38.0%   | 82.7%    | -18.0%  | 0.1   | 2.0    |
| 2021-2023  | 3.0%     | 82.7%    | 2.0%    | 0.0   | 2.9    |
| 2022-2024  | 210.0%   | 82.7%    | 189.0%  | 0.0   | 13.5   |
| 2023-2025  | 449.0%   | 79.6%    | 382.0%  | -0.0  | 37.5   |

*   **CAGR (Compound Annual Growth Rate):** Shows strong growth in recent periods (2022-2025).
*   **MDD (Maximum Drawdown):** High MDD indicates significant volatility and risk.
*   **Alpha:**  Indicates strong outperformance relative to the market, especially in the most recent period (2023-2025).
*   **Beta:** Beta near zero suggests the stock's price is largely independent of broader market movements, which is unexpected. This may reflect the high degree of unsystematic risk associated with this company, or errors in calculation.
*   **Cap (B):**  Indicates the company's market capitalization in billions, which is growing.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 70.65
*   **Last Market Data:** Price: 70.12, Previous Close: 70.65, Change: -0.75
*   **5-day SMA:** 74.62
*   **20-day SMA:** 57.72
*   **60-day SMA:** 56.93

**Analysis:**

The stock price closed at 70.65, with the last market data showing a slight decrease (-0.75 change). The 5-day SMA (74.62) is above the 20-day (57.72) and 60-day (56.93) SMAs, suggesting short-term upward momentum. The 20-day and 60-day SMAs being close suggest the longer-term trend is stabilizing, but the difference between the 5-day and 20-day SMA suggests a potential pullback.

**3. Technical Indicators and Analysis**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 69.74 (Approaching overbought territory)
*   **PPO:** 3.76
*   **Hybrid Signal:** 90% Buy (MRI: 0.80)
*   **Recent Relative Divergence Change (20 days):** 15.7 (+)
*   **Expected Return (%):** 4.7%

**Analysis:**

*   **MRI:** The MRI of 0.9 indicates a "Medium Investment Recommended" level of risk.
*   **RSI:** The RSI of 69.74 is close to the overbought threshold of 70, indicating the stock may be due for a pullback.
*   **PPO:** The Positive PPO suggests the short-term moving average is above the long-term moving average.
*   **Hybrid Signal:** The 90% Buy signal suggests strong buy sentiment, but with the note that this is a "safe" pick with an MRI of 0.80.
*   **Relative Divergence Change:** The recent increase in relative divergence change indicates short-term upward momentum (단기상승).
*   **Expected Return:** The 4.7% expected return suggests moderate future gains compared to the S&P 500 over a 2+ year investment horizon.
*   The negative change in the last market data (price 70.12, change -0.75) indicates a slight recent downward fluctuation.

**4. Recent News & Significant Events**

*   **Positive Catalysts:**
    *   Rocket Lab's shift to a major defense prime after an $805M satellite award (Needham).
    *   A large contract win triggered a rare bullish signal (Investor's Business Daily).
    *   TipRanks reports on Rocket Lab’s "Big-League Turn Empowers Stock Bulls."

*   **Mixed/Cautionary Signals:**
    *   Rocket Lab stock falls after an $816M Space Force contract (ts2.tech).
    *   MarketBeat questions if a 6% price drop signals time to sell.
    *   Insider sales disclosures may be cause for concern (ts2.tech).

**Analysis:**

Recent news is mixed, with positive news centered on large contract wins, defense prime status, and bullish sentiment. However, some reports indicate potential selling pressure after the price increase, insider sales, and questions about the stock's valuation. This suggests caution is warranted, and investors should be aware of potential volatility.

**4-2. Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.79 (Buy)
*   **Number of Opinions:** 12
*   **Target Price:** Avg: 68.75 / High: 90.00 / Low: 47.00

**Analysis:**

Analysts have a consensus rating of "Buy" for Rocket Lab, with a mean rating indicating a strong buy sentiment. The average target price of 68.75 is slightly below the current price of 70.65, suggesting limited upside potential based on analyst estimates. The high target price of 90.00 indicates some analysts believe the stock has significant growth potential, while the low target of 47.00 suggests some analysts are bearish.

**5. Recent Earnings Analysis**

| 날짜         | EPS   | 매출      |
|--------------|-------|-----------|
| 2025-11-10   | -0.03 | 0.16 B$  |
| 2025-08-07   | -0.13 | 0.14 B$  |
| 2025-05-08   | -0.12 | 0.12 B$  |
| 2024-11-12   | -0.1  | 0.10 B$  |
| 2025-11-10   | -0.1  | 0.10 B$  |

**Analysis:**

*   Rocket Lab is currently unprofitable with negative EPS (Earnings Per Share).
*   Revenue is growing from 0.10B to 0.16B, indicating increasing sales.
*   The most recent EPS improved significantly (-0.03) compared to previous quarters, which is a positive sign.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $0.16B  | 36.96%        |
| 2025-06-30 | $0.14B  | 32.10%        |
| 2025-03-31 | $0.12B  | 28.76%        |
| 2024-12-31 | $0.13B  | 27.81%        |
| 2024-09-30 | $0.10B  | 26.71%        |

**Capital and Profitability:**

| Quarter    | Equity | ROE      |
|------------|--------|----------|
| 2025-09-30 | $1.28B | -1.43%   |
| 2025-06-30 | $0.69B | -9.65%   |
| 2025-03-31 | $0.43B | -14.05%  |
| 2024-12-31 | $0.38B | -13.69%  |
| 2024-09-30 | $0.42B | -12.37%  |

**Analysis:**

*   **Revenue:** Revenue is consistently growing.
*   **Profit Margin:** Profit margins are improving.
*   **Equity:** Equity has increased significantly in the most recent quarter.
*   **ROE:** While still negative, ROE (Return on Equity) is improving.  This is primarily due to the large increase in Equity.

**7. Comprehensive Analysis (Summary)**

Rocket Lab (RKLB) has shown significant outperformance compared to the S&P 500. It has been driven by increasing revenue, improving profit margins, and positive news surrounding large contract wins and analyst upgrades.

**Key Observations:**

*   **Growth Stock with High Volatility:** RKLB demonstrates high growth potential, but with significant volatility, as evidenced by its high MDD.
*   **Strong Revenue Growth:** Revenue and profit margins are trending upward, which is a positive sign.
*   **Mixed Signals:** Analyst opinions are generally positive, but target prices vary. Recent news is mixed, with positive catalysts offset by potential concerns about profit-taking and insider sales.
*   **Technical Indicators:** The RSI is near overbought levels, suggesting a potential pullback. The 5-day SMA indicates a recent upward trend but may be subject to correction.
*   **Not Yet Profitable:** The company is not yet profitable, but EPS is improving.
* **Low beta:** The low/near-zero beta indicates that RKLB's performance is largely independent of broader market movements. This may reflect the high degree of unsystematic risk associated with this company, or errors in calculation.

**Recommendation:**

Rocket Lab (RKLB) presents a high-risk, high-reward investment opportunity. Given the strong growth, improving financial metrics, and positive catalysts, it may be attractive to investors with a high risk tolerance and a long-term investment horizon. However, the high valuation, recent price volatility, and potential for profit-taking necessitate caution. Investors should carefully monitor news, analyst ratings, and technical indicators before making an investment decision.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.